{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:50:44Z","timestamp":1786981844448,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100021055","name":"Apnimed","doi-asserted-by":"publisher","award":["Apnimed"],"award-info":[{"award-number":["Apnimed"]}],"id":[{"id":"10.13039\/100021055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11325-024-03113-1","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T08:01:39Z","timestamp":1726905699000},"page":"2571-2580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Alan R.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Corser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Pho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-0335","authenticated-orcid":false,"given":"Luigi","family":"Taranto-Montemurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"6","key":"3113_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/jappl.1978.44.6.931","volume":"44","author":"JE Remmers","year":"1978","unstructured":"Remmers JE, deGroot WJ, Sauerland EK, Anch AM (1978) Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44(6):931\u2013938","journal-title":"J Appl Physiol"},{"key":"3113_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1569-9048(03)00079-X","volume":"136","author":"NM Punjabi","year":"2003","unstructured":"Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O\u2019Donnell CP (2003) Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136:2\u20133","journal-title":"Respir Physiol Neurobiol"},{"issue":"8","key":"3113_CR3","doi-asserted-by":"publisher","first-page":"e1000132","DOI":"10.1371\/journal.pmed.1000132","volume":"6","author":"NM Punjabi","year":"2009","unstructured":"Punjabi NM et al (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6(8):e1000132","journal-title":"PLoS Med"},{"issue":"8","key":"3113_CR4","first-page":"1079","volume":"31","author":"NS Marshall","year":"2008","unstructured":"Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079\u20131085","journal-title":"Sleep"},{"issue":"19","key":"3113_CR5","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1056\/NEJMoa043104","volume":"353","author":"HK Yaggi","year":"2005","unstructured":"Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034\u20132041","journal-title":"N Engl J Med"},{"issue":"8","key":"3113_CR6","first-page":"1071","volume":"31","author":"T Young","year":"2008","unstructured":"Young T et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071\u20131078","journal-title":"Sleep"},{"key":"3113_CR7","doi-asserted-by":"crossref","unstructured":"Hla KM, Skatrud JB, Finn L, Palta M, Young T (2002) The effect of correction of sleep-disordered breathing on BP in untreated hypertension, Chest, vol. 122, no. 4, pp. 1125\u201332, Oct","DOI":"10.1378\/chest.122.4.1125"},{"issue":"9464","key":"3113_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0140-6736(05)71141-7","volume":"365","author":"JM Marin","year":"2005","unstructured":"Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046\u20131053","journal-title":"Lancet"},{"key":"3113_CR9","unstructured":"Frost, Sullivan, Hidden Health Crisis Costing America Billions: Underdiagnosing and Undertreating Obstructive Sleep Apnea Draining Healthcare System (2016). American Academy of Sleep Medicine, [Online]. Available: https:\/\/aasm.org\/resources\/pdf\/sleep-apnea-economic-crisis.pdf"},{"issue":"4","key":"3113_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1164\/ajrccm\/147.4.887","volume":"147","author":"NB Kribbs","year":"1993","unstructured":"Kribbs NB et al (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Amer Rev Respir Dis 147(4):887\u2013895","journal-title":"Amer Rev Respir Dis"},{"issue":"4","key":"3113_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/sleep\/20.4.278","volume":"20","author":"TE Weaver","year":"1997","unstructured":"Weaver TE et al (1997) Night-to-night variability in CPAP use over the first three months of treatment. Sleep 20(4):278\u2013283","journal-title":"Sleep"},{"key":"3113_CR12","doi-asserted-by":"publisher","unstructured":"McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H (2007) A nasal cannula can be used to treat obstructive sleep apnea, American Journal of Respiratory & Critical Care Medicine, vol. 176, no. 2, pp. 194\u2013200, Jul. https:\/\/doi.org\/10.1164\/rccm.200609-1336OC","DOI":"10.1164\/rccm.200609-1336OC"},{"issue":"6","key":"3113_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.smrv.2004.04.002","volume":"8","author":"PA Cistulli","year":"2004","unstructured":"Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA (2004) Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Med Rev 8(6):443\u2013457","journal-title":"Sleep Med Rev"},{"key":"3113_CR14","doi-asserted-by":"publisher","unstructured":"Camacho M, Song SA, Tolisano AM (Sep. 2016) Oral pressure therapy (winx) for obstructive sleep apnea: a meta-analysis updating the systematic review. Sleep Breath 20(3):1011\u20131012. https:\/\/doi.org\/10.1007\/s11325-016-1350-z","DOI":"10.1007\/s11325-016-1350-z"},{"issue":"2","key":"3113_CR15","first-page":"50","volume":"35","author":"J Ulfberg","year":"1997","unstructured":"Ulfberg J, Fenton G (1997) Effect of Breathe Right nasal strip on snoring. Rhinology 35(2):50\u201352","journal-title":"Rhinology"},{"key":"3113_CR16","doi-asserted-by":"publisher","unstructured":"Patil SP, Schneider H, Marx JJ, Gladmon E, Schwartz AR, Smith PL (2007) Neuromechanical control of upper airway patency during sleep, Journal of Applied Physiology, vol. 102, no. 2, pp. 547\u2013556, Feb. https:\/\/doi.org\/10.1152\/japplphysiol.00282.2006","DOI":"10.1152\/japplphysiol.00282.2006"},{"key":"3113_CR17","doi-asserted-by":"publisher","unstructured":"McGinley BM, Schwartz AR, Schneider H, Kirkness JP, Smith PL, Patil SP (2008) Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea, Journal of Applied Physiololgy, vol. 105, no. 1, pp. 197\u2013205, Jul. https:\/\/doi.org\/10.1152\/japplphysiol.01214.2007","DOI":"10.1152\/japplphysiol.01214.2007"},{"issue":"10","key":"3113_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/sleep\/19.10.827","volume":"19","author":"RL Horner","year":"1996","unstructured":"Horner RL (1996) Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep 19(10):827\u2013853","journal-title":"Sleep"},{"key":"3113_CR19","doi-asserted-by":"publisher","unstructured":"Amorim MR et al (2021) The Effect of DREADD activation of leptin receptor positive neurons in the Nucleus of the Solitary Tract on Sleep Disordered Breathing. Int J Mol Sci 22(13). https:\/\/doi.org\/10.3390\/ijms22136742","DOI":"10.3390\/ijms22136742"},{"key":"3113_CR20","doi-asserted-by":"publisher","unstructured":"Pho H et al (Jan. 2016) The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob\/ob mouse. J Appl Physiol 120(1):78\u201386. https:\/\/doi.org\/10.1152\/japplphysiol.00494.2015","DOI":"10.1152\/japplphysiol.00494.2015"},{"key":"3113_CR21","doi-asserted-by":"crossref","unstructured":"Polotsky M et al (May 2012) Effects of leptin and obesity on the upper airway function. J Appl Physiol 112(Electronic):1522\u20131601","DOI":"10.1152\/japplphysiol.01222.2011"},{"key":"3113_CR22","doi-asserted-by":"publisher","unstructured":"Taranto-Montemurro L et al (2018) Nov., The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial, Am J Respir Crit Care Med, https:\/\/doi.org\/10.1164\/rccm.201808-1493OC","DOI":"10.1164\/rccm.201808-1493OC"},{"key":"3113_CR23","doi-asserted-by":"publisher","unstructured":"Schweitzer PK et al (2023) Oct., The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial, Am J Respir Crit Care Med, https:\/\/doi.org\/10.1164\/rccm.202306-1036OC","DOI":"10.1164\/rccm.202306-1036OC"},{"key":"3113_CR24","doi-asserted-by":"publisher","unstructured":"Aishah A et al (2023) Apr., One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial, Ann Am Thorac Soc, vol. 20, no. 4, pp. 584\u2013595, https:\/\/doi.org\/10.1513\/AnnalsATS.202206-492OC","DOI":"10.1513\/AnnalsATS.202206-492OC"},{"issue":"9302","key":"3113_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0140-6736(02)07445-7","volume":"359","author":"JC Pepperell","year":"2002","unstructured":"Pepperell JC et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204\u2013210","journal-title":"Lancet"},{"issue":"10","key":"3113_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1164\/rccm.201106-0964OC","volume":"184","author":"M Kohler","year":"2011","unstructured":"Kohler M et al (2011) Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respiratory Crit Care Med 184(10):1192\u20131199","journal-title":"Am J Respiratory Crit Care Med"},{"issue":"6","key":"3113_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1164\/ajrccm.161.6.16166a","volume":"161","author":"RJ Davies","year":"2000","unstructured":"Davies RJ, Stradling JR (2000) The efficacy of nasal continuous positive Airway pressure in the treatment of obstructive sleep apnea syndrome is proven. Am J Respiratory Crit Care Med 161(6):1775\u20131776","journal-title":"Am J Respiratory Crit Care Med"},{"key":"3113_CR28","doi-asserted-by":"publisher","unstructured":"Leenen FHH, Ruzicka M, Floras JS (2012) Central sympathetic inhibition by mineralocorticoid receptor but not angiotensin II type 1 receptor blockade: are prescribed doses too low? Hypertension, vol. 60, no. 2, pp. 278\u2013280, Aug. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.197012","DOI":"10.1161\/HYPERTENSIONAHA.112.197012"},{"key":"3113_CR29","doi-asserted-by":"publisher","unstructured":"Gaddam K et al (2010) Aug., Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report, J Hum Hypertens, vol. 24, no. 8, pp. 532\u2013537, https:\/\/doi.org\/10.1038\/jhh.2009.96","DOI":"10.1038\/jhh.2009.96"},{"issue":"14","key":"3113_CR30","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.109.902452","volume":"121","author":"D Yumino","year":"2010","unstructured":"Yumino D et al (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121(14):1598\u20131605","journal-title":"Circulation"},{"key":"3113_CR31","doi-asserted-by":"publisher","unstructured":"Khurshid K et al (Aug. 2016) Effect of antihypertensive medications on the severity of obstructive sleep apnea: a systematic review and Meta-analysis. J Clin Sleep Med 12(08):1143\u20131151. https:\/\/doi.org\/10.5664\/jcsm.6054","DOI":"10.5664\/jcsm.6054"},{"issue":"7","key":"3113_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/sleep\/21.7.749","volume":"21","author":"CW Whitney","year":"1998","unstructured":"Whitney CW et al (1998) Reliability of scoring respiratory disturbance indices and sleep staging. Sleep 21(7):749\u2013757","journal-title":"Sleep"},{"key":"3113_CR33","doi-asserted-by":"publisher","unstructured":"Sands SA et al (Jan. 2018) Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med 197(9):1187\u20131197. https:\/\/doi.org\/10.1164\/rccm.201707-1435OC","DOI":"10.1164\/rccm.201707-1435OC"},{"issue":"6","key":"3113_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1164\/ajrccm\/141.6.1569","volume":"141","author":"MJ Wasicko","year":"1990","unstructured":"Wasicko MJ, Hutt DA, Parisi RA, Neubauer JA, Mezrich R, Edelman NH (1990) The role of vascular tone in the control of upper airway collapsibility. Am Rev Respir Dis 141(6):1569\u20131577","journal-title":"Am Rev Respir Dis"},{"key":"3113_CR35","doi-asserted-by":"publisher","unstructured":"Gaddam KK et al (2008) Jun., Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion, Arch Intern Med, vol. 168, no. 11, pp. 1159\u20131164, https:\/\/doi.org\/10.1001\/archinte.168.11.1159","DOI":"10.1001\/archinte.168.11.1159"},{"key":"3113_CR36","doi-asserted-by":"publisher","unstructured":"Taranto-Montemurro L et al (2020) Jun., Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits, Chest, vol. 157, no. 6, pp. 1626\u20131636, https:\/\/doi.org\/10.1016\/j.chest.2020.01.012","DOI":"10.1016\/j.chest.2020.01.012"},{"key":"3113_CR37","doi-asserted-by":"publisher","unstructured":"Schweitzer PK, Maynard JP, Wylie PE, Emsellem HA, Sands SA (May 2023) Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility. Sleep Breath 27(2):495\u2013503. https:\/\/doi.org\/10.1007\/s11325-022-02634-x","DOI":"10.1007\/s11325-022-02634-x"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-024-03113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-024-03113-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-024-03113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T08:07:53Z","timestamp":1731658073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-024-03113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3113"],"URL":"https:\/\/doi.org\/10.1007\/s11325-024-03113-1","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the (place name of institution and\/or national research committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Advarra, 6100 Merriweather Dr. Ste 600, Columbia, MD 21044.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Name of the ethic committee"}},{"value":"Within the past two years, AS reports sponsored research from NIH\/NHLBI, Apnimed, Itamar\/Zoll, and Periodic Breathing LLC. AS provided consultancy for Apnimed, Humannity Foundation, Invicta Medical, Itamar\/Zoll, LivaNova, Lunair, Nyxoah, Periodic Breathing, Respicardia\/Zoll, Sonosa. RB reports sponsored research for Apnimed, Avadel, Axsome, Bresotec, Bayer, Idorsia, Suven, Jazz, Balance, NLS, Vanda, Merck, Eisai, Philips, Fresca, Takeda, Liva Nova, Roche, Sanofi, Sommetrics, Noctrix, Oura. RB provided consultancy to Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda, Oventus, Axsome. He provided consultancy for Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda, Oventus, Axsome. Speakers Bureau for Jazz, Eisai, Harmony, Axsome, Idorsia. RB is a shareholder of WaterMark Medical, Healthy Humming, LLC and sits on the board of directors of WaterMark Medical. BC reports sponsored research from Apnimed, Avadel, Axsome, Harmony, Jazz, NLS, Takeda, Zefra Therapeutics. BC has been consultant for Avadel and speaker for Axsome and Jazz Pharmaceuticals. HP and LT-M are Apnimed employees. LH has no conflict to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}